Clinical Trials Logo

Nesfatin-1 clinical trials

View clinical trials related to Nesfatin-1.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT04298515 Recruiting - Obesity Clinical Trials

Nesfatin-1 Level in Patients With Type 2 Diabetes, Insulin Resistance and Obesity

Start date: March 2, 2020
Phase: N/A
Study type: Interventional

This research was planned to determine the level of nesfatin-1, known as satiety hormone, in type 2 diabetes, insulin diabetes and obesity patients and to determine whether there is a relationship between patients' energy intake levels. Additionally, it was aimed to evaluate the relationship between patients' nesfatin-1 values and serum glucose, insulin, lipid concentrations.